Auph short interest.

Institutional Owners: 318 total, 304 long only, 0 short only, 14 long/short - change of 1.92% MRQ Average Portfolio Allocation: 0.0605 % - change of -12.95% MRQ The average one-year price target for AUPH / Aurinia Pharmaceuticals Inc is $14.28. The forecasts range from a low of $12.12 to a high of $15.75. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond ... Short Squeeze - Canada; Short Squeeze - Hong Kong; Highest Cost to Borrow; Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium …WebThe settlement with Sun Pharma appeared to spark some renewed speculation that the company could be a takeover target again. Dealreporter speculated at the time that Aurinia (AUPH) could be viewed as a takeout candidate with the patent overhang lifted. Aurinia (AUPH) short interest is 10.7%.

AUPH / Aurinia Pharmaceuticals Inc short borrow fee rates are shown in the following table. This table shows the interest rate that must be paid by a short seller of US:AUPH to the lender of that security. This fee is shown as an annual percentage rate (APR).Finding the right furnished short term rental can be a daunting task. With so many options available, it can be difficult to know which one is best for you. Here are some tips to help you make the right choice when selecting a furnished sho...Percentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month. Percent of Float

Jul 7, 2023 · NP. VQNPX - Vanguard Growth and Income Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value. 28,200. -40.63.

This page provides short interest, short volume, short volume ratio, short borrow rates, and short squeeze score for the security. US: AUPH / Aurinia Pharmaceuticals Inc - Insider Trading Report This page provides data on the corporate insiders of Aurinia Pharmaceuticals Inc and their trades, trade performance, and predictive analysis.Short Interest. Prev. Close. Compare to Peers. More on AUPH. Trending Analysis. Trending News. Seeking Alpha - Power to Investors. Power to Investors. Follow us. Download app. Subscription Support ...Interest Coverage Financials. AUPH's profit margin has increased... subscribe to Premium to read more. Profit Margin Growth Financials. ... AUPH's cash and short-term investments... subscribe to Premium to read more. Debt Coverage Financials. AUPH vs Biotech Stocks. Ticker Market Cap 1d % P/E P/B; AUPH: $1.18B +4.44%-15.53x:In Leo Tolstoy’s short story “What Men Live By,” the angel Michael learns that people dwell best when in love and that they do not always know what is in their best interests. Michael also learns that people live best by loving others and n...

Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.Web

Get the latest Aurinia Pharmaceuticals Inc (AUPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Nov 24, 2023 · Short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) saw shorts transact 17.28 million shares and set a 9.89 days time to cover. Analysts on Wall Street suggest a consensus price target of $13.21, implying an increase of 29.75% to the stock’s recent value. are three bearish stocks that you should think about shorting this week, writes technical analyst Bob Lang in his latest edition of Bearish Bets....TSM Each week we identify names that look bearish and may present interesting investing oppo...Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has seen a decrease in hedge fund interest in recent months. Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) was in 24 hedge funds' portfolios at the end of ...Short Interest Change. -0.88%. Percent of Float. 13.23%. Overview. Complete Aurinia Pharmaceuticals Inc. stock information by Barron's. View real-time AUPH stock price and news, along with...May 22, 2023 · @PITX3 not really great short squeeze potential, more like short caress. 11% of float takes 5 - 6 days to cover. From mid-April to mid-May the short position decreased by 2M down to 15.5M, 11% of ...

Live Short Interest data, Utilization, Cost to borrow and much more for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH Mar 23, 2023 · Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 6.5% amid renewed takeover speculation. There's speculation than unnamed suitor may be eyeing a takeover of Aurinia ( AUPH ), according to a Betaville ... As of March 31, 2023, Aurinia held cash, cash equivalents, and short-term investments of $361.5 million, down from $389.4 million at the end of 2022 due to continued investments in commercial ...Today's Open Interest: The total open interest for all option contracts (across all expiration dates). Open Int (30-Day) : The average total open interest for all option contracts …2021-12-28 Short sale volume (not short interest) for $FSR is 66%. http://shortvolumes.com/?t=FSR $KDP 44% $TNA 40% $SPDW 77% $AUPH 41%. 29 Dec 2021WebBBBY short interest is up more than 17.5m shares. r/Shortsqueeze • Bed Bath and to infinity and Beyond - Why BBBY is legitimately the closest play to GME & AMCThe main competitors of U.S. Physical Therapy include InnovAge (INNV), DocGo (DCGO), Sharecare (SHCR), LifeStance Health Group (LFST), Privia Health Group (PRVA), Vir Biotechnology (VIR), Alignment Healthcare (ALHC), AbCellera Biologics (ABCL), Aurinia Pharmaceuticals (AUPH), and Disc Medicine (IRON). These companies are all part of the ...

Principal Financial Group Inc. cut its position in Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Free Report) (TSE:AUP) by 8.4% in the 2nd quarter, according to its most recent filing with the ...

Cantor Fitzgerald Reiterates Aurinia Pharmaceuticals (AUPH) Overweight Recommendation. ... Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand.Some thoughts on AUPH: 1. As cited, AUPH reported Lupkynis sales +46% YOY, +20% over Q1, and raised full year guidance to $150 million - $160 million, but admittedly is only scratching the surface ...Feb 28, 2022 · For 2022, Aurinia ( AUPH) projects net revenue from sales of Lupkynis to reach $115M-135M. Several days ago, shares of the company surged in reaction to upbeat remarks made by CEO on its sales ... Overview of financial data and news for Aurinia Pharmaceuticals Inc., Nasdaq:AUPHWhen it comes to summer fashion, finding the perfect pair of shorts can be a challenge. Many people prioritize either comfort or style, but why not have both? That’s where Chubbies Shorts come in.Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals.

AUPH - Aurinia Pharmaceuticals Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.Web

Aurinia Pharmaceuticals (AUPH) has begun to examine strategic alternatives that could include a potential sale or merger. ... Also, with 11%+ short interest, there should be some "motivated ...

AUPH short interest is 8.5%. Also see, Alnylam Pharma is said to be a potential target for Novartis. Recommended For You. Comments (34) Newest. Publish. Have a tip? Submit confidentially to our ...The Whisper Report ® Grades Earnings Guidance Reactions Strategies Earnings Screener Short Interest ... AUPH. Aurinia Pharm Ord. $8.65. -0.52. -5.67%. Overview ...Cash received for interest $ 2,713 $ 528 Cash paid for income taxes $ (277) $ (779) Cash paid for amounts included in the measurement of lease liabilities $ (531) $ (572) Supplemental disclosure of noncash transactions: Finance right-of-use asset obtained in exchange for lease obligations (monoplant) $ 117,622 $ —Global Coverage. Comprehensive ownership data of US Institutions, Mutual Funds, and ETFs targeting equities and bonds in mature, emerging, and frontier markets. Activist Investor 13D Filings. Beneficial Ownership 13G Filings. Institutional Ownership 13F Filings. Insider 3, 4 and 5 Filings.WebThe short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is 17.19 million shares and it means that shorts have 11.64 day(s) to cover. The consensus price target of analysts on Wall Street is $13.21, which implies an …Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 5% amid speculation the company may be a takeover target after Tuesday's patent settlement with Sun Pharmaceuticals. Aurinia ( AUPH) surged 38% on ...Aurinia Pharmaceuticals Stock (NASDAQ: AUPH) stock price, news, charts, stock research, ... Profile News Analyst Ratings Guidance Dividends Earnings Insider Trades Ideas …As of November 15th, there was short interest totaling 30,500 shares, a decrease of 27.2% from the October 31st total of 41,900 shares. Based on an average daily volume of 37,400 shares, the short-interest ratio is presently 0.8 days. Currently, 1.0% of the company's shares are sold short. ... (AUPH), Arch Therapeutics ...WebThe Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...

The largest shareholder of Aurinia Pharmaceuticals (NASDAQ:AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ...Market Capitalization. $1.24 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $14.00. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media.Nov 29, 2023 · Short Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to Cover Aurinia Pharmaceuticals has a short interest ratio ("days to cover") of 9.2. Change versus previous month Instagram:https://instagram. skilz stockmost predictable stockswhen can pre order iphone 15platforms like robinhood Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.Web bzfd newssafe growth stocks Mar 24, 2023 · AUPH has a market cap of $1.3bn and a cash balance of $389mn. Research and development expenses were USD 9.9 million for 4Q. Selling, general and administrative expenses, inclusive of share-based ... best third party car rental insurance Jul 18, 2023 · Learn more about AUPH stock here. Skip to content. Explore Alpha Picks; ... Interest income rose to $3.8 million due to higher yields from increased interest rates. ... cash equivalents, and short ... Overview of financial data and news for Aurinia Pharmaceuticals Inc., Nasdaq:AUPH